AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Leurotime 11.25 Injection

Prescription Icon
Prescription Required

Marketer

Axiommax Oncology Pvt Ltd

Salt Composition

Leuprolide (11.25mg)

Overview Leurotime 11.25 Injection

Leuprolide acetate 11.25 mg injection treats prostate cancer, endometriosis (excessive uterine lining growth causing pain, heavy/irregular periods), uterine fibroids, and central precocious puberty (early onset puberty). Administered subcutaneously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Frequent side effects include decreased sex drive, excessive sweating, tiredness, muscle weakness, and hot flushes. Prolonged use can weaken bones, reducing bone density; calcium and vitamin D supplementation is advised. Amenorrhea (absence of menstruation) for 7-12 weeks is possible; persistent bleeding necessitates medical consultation. Inform your doctor of alcohol or tobacco use, osteoporosis, and all current medications, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.

Uses of Leurotime 11.25 Injection

Managing prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Major Benefits of Leurotime 11.25 Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Leurotime 11.25 Injection:

  • Decreased libido
  • Testicular atrophy
  • Increased sweating
  • Fatigue
  • Muscle weakness
  • Erectile dysfunction
  • Hot flashes

How to use Leurotime 11.25 Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Leurotime 11.25 Injection works:

Leurotime 11.25 Injection lowers sex hormone production, specifically testosterone in men and estrogen in women. Its mechanism involves suppressing testosterone levels in the male bloodstream. In women, it inhibits ovarian hormone synthesis, consequently reducing estrogen and thus menstrual flow.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use of alcohol alongside Leurotime 11.25 Injection requires careful consideration. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Administering Leurotime 11.25 Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in both animal and human subjects has revealed considerable adverse effects on fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Leurotime 11.25 Injection with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Administering Leurotime 11.25 Injection may induce adverse reactions that impair driving capabilities. Refrain from driving or operating equipment if drowsiness, dizziness, or visual problems occur during treatment with Leurotime 11.25 Injection.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Leurotime 11.25 Injection to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Leurotime 11.25 Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Leurotime 11.25 Injection :

Should you forget a Leurotime 11.25 Injection dose, seek your physician's advice.

Facts to Know About Leurotime 11.25 Injection

LabelValue
Type of Compound Gonadotropin-releasing hormone agonist
Potential for Dependence None.
Type of Medication OBSTETRIC AND GYNECOLOGICAL

FAQs on Leurotime 11.25 Injection

Leurotime 11.25 Injection is not a chemotherapeutic agent. It's a synthetic hormone analog indicated for managing hormone-responsive disorders in both male and female patients.
Leurotime 11.25 Injection can disrupt menstrual cycles, often resulting in amenorrhea. Occasional vaginal bleeding may also occur. Consult your physician for evaluation and guidance should this happen.
Leurotime 11.25 Injection is a hormone-based drug affecting reproductive hormones in women. Its use is contraindicated in pregnant or potentially pregnant women due to the risk of fetal harm and potential miscarriage. Pregnant women, or those planning pregnancy, must disclose this information to their physician prior to commencing treatment.
Leurotime 11.25 Injection can negatively impact bone health. Its use may reduce bone mineral density, leading to weakened bones. Prior to treatment initiation in women, bone density evaluation is recommended. Women at higher risk of osteoporosis require close observation and management. Supplemental medication to mitigate osteoporosis may be prescribed for individuals experiencing bone mineral density reduction.
Leurotime 11.25 Injection can elevate blood sugar, potentially worsening diabetic blood glucose management and increasing the risk of new-onset diabetes. Consequently, regular blood glucose and/or HbA1c monitoring is crucial to track glycemic control. Report any issues to your physician. Diabetics using this medication should increase the frequency of their blood sugar checks.
Leurotime 11.25 Injection
8,877
MRP 10,300
13% off